Weiyan Cheng

608 total citations
25 papers, 499 citations indexed

About

Weiyan Cheng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiyan Cheng has authored 25 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiyan Cheng's work include Cancer, Hypoxia, and Metabolism (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Weiyan Cheng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Weiyan Cheng collaborates with scholars based in China and United States. Weiyan Cheng's co-authors include Xin Tian, Xiaojian Zhang, Wei Han, Zhiheng Yang, Suhua Wang, Quancheng Kan, Yueqin Wang, Yongzhou Hu, Ying Li and Shasha Li and has published in prestigious journals such as Chemical Communications, Sensors and Actuators B Chemical and European Journal of Medicinal Chemistry.

In The Last Decade

Weiyan Cheng

23 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyan Cheng China 13 304 144 113 65 39 25 499
Mingsong Shi China 14 261 0.9× 114 0.8× 131 1.2× 27 0.4× 32 0.8× 58 470
Sushil Kumar Gupta India 10 181 0.6× 180 1.3× 116 1.0× 34 0.5× 13 0.3× 22 486
Sushilla van Schoonhoven Austria 16 285 0.9× 222 1.5× 110 1.0× 65 1.0× 54 1.4× 23 556
Shigeki Kashimoto Japan 14 339 1.1× 185 1.3× 243 2.2× 25 0.4× 53 1.4× 21 733
Osvaldo dos Santos United States 17 583 1.9× 218 1.5× 393 3.5× 77 1.2× 40 1.0× 21 1.0k
Jo Ann W. Byl United States 16 607 2.0× 268 1.9× 242 2.1× 17 0.3× 28 0.7× 24 807
Monish Jain United States 9 181 0.6× 60 0.4× 169 1.5× 35 0.5× 38 1.0× 17 525
Tiantao Gao China 12 297 1.0× 96 0.7× 55 0.5× 35 0.5× 48 1.2× 18 460
Daniel H. O’Donovan United Kingdom 16 451 1.5× 138 1.0× 301 2.7× 36 0.6× 31 0.8× 27 833

Countries citing papers authored by Weiyan Cheng

Since Specialization
Citations

This map shows the geographic impact of Weiyan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Cheng more than expected).

Fields of papers citing papers by Weiyan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Cheng. The network helps show where Weiyan Cheng may publish in the future.

Co-authorship network of co-authors of Weiyan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyan Cheng. A scholar is included among the top collaborators of Weiyan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyan Cheng. Weiyan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chunxia, Wenxin Wang, Haoyang Chen, et al.. (2025). Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. European Journal of Medicinal Chemistry. 292. 117649–117649.
2.
Liu, Chunxia, Ning Wang, Lei Zhao, et al.. (2025). Design, synthesis, and biological evaluation of 2, 6-di-substituted indole derivatives as METTL3 inhibitors. European Journal of Medicinal Chemistry. 300. 118134–118134.
3.
Cheng, Weiyan, Shasha Li, Suhua Wang, et al.. (2023). Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands. Bioorganic & Medicinal Chemistry. 82. 117237–117237. 19 indexed citations
4.
Yang, Zhiheng, Yu Cao, Limin Kong, et al.. (2023). Small molecules as modulators of the proteostasis machinery: Implication in cardiovascular diseases. European Journal of Medicinal Chemistry. 264. 116030–116030. 2 indexed citations
5.
Li, Shasha, et al.. (2023). Chemoproteomics reveals arctigenin as a phagophore-closure blocker via targeting ESCRT-I subunit VPS28. Bioorganic Chemistry. 134. 106457–106457. 1 indexed citations
6.
Jia, Tingting, Jiankang Zhang, Huajian Zhu, et al.. (2023). Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer. Bioorganic & Medicinal Chemistry. 91. 117384–117384. 4 indexed citations
7.
Jia, Tingting, Chong Zhang, Linghui Zeng, et al.. (2022). Design, synthesis and biological evaluation of novel tumor hypoxia-activated EGFR tyrosine kinase inhibitors. Bioorganic Chemistry. 129. 106138–106138. 4 indexed citations
8.
Li, Zeyun, Mei Su, Weiyan Cheng, et al.. (2021). Pharmacokinetics, Urinary Excretion, and Pharmaco-Metabolomic Study of Tebipenem Pivoxil Granules After Single Escalating Oral Dose in Healthy Chinese Volunteers. Frontiers in Pharmacology. 12. 696165–696165. 6 indexed citations
9.
Han, Wei, Guanghua Wu, Yueqin Wang, et al.. (2021). Dual-responsive fluorescent probe for imaging NAD(P)H and mitochondrial viscosity and its application in cancer cell ferroptosis. Sensors and Actuators B Chemical. 350. 130862–130862. 37 indexed citations
10.
Cheng, Weiyan, Shasha Li, Suhua Wang, et al.. (2021). Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia. Chemical Communications. 57(95). 12852–12855. 84 indexed citations
11.
Yang, Zhiheng, et al.. (2020). Iridium‐Catalysed Reductive Deoxygenation of Ketones with Formic Acid as Traceless Hydride Donor. Advanced Synthesis & Catalysis. 362(23). 5496–5505. 23 indexed citations
12.
Han, Wei, et al.. (2020). Vimentin-targeting AIEgen-peptide conjugates: Wash-free fluorescence detection of EMT-type cancer cells and tissues. Sensors and Actuators B Chemical. 321. 128536–128536. 13 indexed citations
13.
Kong, Huimin, Weiyan Cheng, Wei Han, et al.. (2019). An overview of recent progress in siderophore-antibiotic conjugates. European Journal of Medicinal Chemistry. 182. 111615–111615. 49 indexed citations
14.
Cheng, Weiyan, Zhiheng Yang, Suhua Wang, et al.. (2019). Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures. European Journal of Medicinal Chemistry. 164. 615–639. 83 indexed citations
15.
Yang, Zhiheng, Weiyan Cheng, & Zeyun Li. (2018). Iridium catalysed highly efficient transfer hydrogenation reduction of aldehydes and ketones in water. Catalysis Communications. 117. 38–42. 17 indexed citations
16.
Cheng, Weiyan, Jianhua Zhou, Xin Tian, & Xiaojian Zhang. (2016). Development of the Third Generation EGFR Tyrosine Kinase Inhibitors for Anticancer Therapy. Current Medicinal Chemistry. 23(29). 3343–3359. 12 indexed citations
17.
Cheng, Weiyan, et al.. (2016). An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors. European Journal of Medicinal Chemistry. 126. 476–490. 32 indexed citations
18.
Cheng, Weiyan, Yongzhou Hu, & Rong Sheng. (2014). Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates. Current Medicinal Chemistry. 21(38). 4374–4404. 9 indexed citations
19.
Cheng, Weiyan, Shijun Zhu, Xiaodong Ma, et al.. (2014). Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia. European Journal of Medicinal Chemistry. 89. 826–834. 26 indexed citations
20.
Zhang, Qiurong, et al.. (2011). 1,2;5,6-Di-O-isopropylidene-3-C-nitromethyl-α-D-allofuranose. Acta Crystallographica Section E Structure Reports Online. 67(6). o1402–o1402. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingsong Shi Breakdown of academic impact, for papers by Sushil Kumar Gupta Breakdown of academic impact, for papers by Sushilla van Schoonhoven Breakdown of academic impact, for papers by Shigeki Kashimoto Breakdown of academic impact, for papers by Osvaldo dos Santos Breakdown of academic impact, for papers by Jo Ann W. Byl Breakdown of academic impact, for papers by Monish Jain Breakdown of academic impact, for papers by Tiantao Gao Breakdown of academic impact, for papers by Daniel H. O’Donovan
Rankless by CCL
2026